Lexeo Therapeutics (LXEO) Preferred Shares (2022)

Lexeo Therapeutics' (LXEO) quarterly Preferred Shares came in at $185.6 million in Q4 2022.

Lexeo Therapeutics (LXEO) Preferred Shares (2022) Analysis & Trends

Lexeo Therapeutics has disclosed Preferred Shares across 1 years of filings, most recently posting $185.6 million for Q4 2022.

Preferred Shares for Q4 2022 came in at $185.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $185.6 million (changed N/A YoY), and the FY2022 annual result was $185.6 million, changed N/A from the prior year.
Preferred Shares came in at $185.6 million for Q4 2022 at Lexeo Therapeutics.
In the past five years, Preferred Shares ranged from a high of $185.6 million in Q4 2022 to a low of $185.6 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Lexeo Therapeutics	405.92 Mn	212.88 Mn	-	-

Download Data

Date	Value
Dec 31, 2022	185.56 Mn